55 results
6-K
MESO
Mesoblast Ltd
29 Feb 24
Current report (foreign)
3:31pm
and development tax incentive
The Group's research and development activities are eligible under the Australian government's Innovation
Australia Research … and expenses primarily comprise foreign exchange gains and losses.
Tax incentives comprise payments from the Australian government’s Innovation Australia
6-K
EX-99.1
MESO
Mesoblast Ltd
22 Nov 23
Current report (foreign)
7:20pm
the advancement of public health and biopharmaceutical innovation. The company's clients include numerous agencies and institutes of the U.S. federal
6-K
EX-99.1
MESO
Mesoblast Ltd
30 Oct 23
Current report (foreign)
7:43am
to a competitive advantage through broadening the talent pool for recruitment of high quality employees, by encouraging innovation and improving
6-K
MESO
Mesoblast Ltd
25 May 23
Current report (foreign)
9:33pm
(2) Research and development tax incentive
The Group's research and development activities are eligible under the Australian government’s Innovation … .
Page 44
Tax incentives comprise payments from the Australian government’s Innovation Australia Research and Development Tax Incentive program
6-K
0xu3kuph
28 Nov 22
Current report (foreign)
6:03am
6-K
EX-99.1
ycsh0b6tzzv9mvp
7 Nov 22
Current report (foreign)
6:41am
6-K
3kt71cxv
2 Jun 22
Current report (foreign)
7:50pm
6-K
oxy95kksq2430 nbp
25 Feb 22
Provided to the Asx Under Listing Rule 4.2A
12:00am
6-K
c1iybornaz o1w266l
24 Nov 21
Current report (foreign)
6:04am
6-K
EX-99.1
vq61rir0e 9qk4qm5he
9 Nov 21
Current report (foreign)
6:09am
6-K
jjych0lon a6
4 Jun 21
Current report (foreign)
6:03am
6-K
dcg51ivr4thov91z
2 Mar 21
Provided to the Asx Under Listing Rule 4.2A
6:02am
6-K
qxue0xr4p56jt6teyr
23 Nov 20
Current report (foreign)
6:05am
6-K
EX-99.1
23ac46waq6 4p57m0a5x
29 Oct 20
Current report (foreign)
6:02am
6-K
EX-99.1
17h8ff
17 Sep 20
Mesoblast Wins 2020 Fierce Biotech Innovation of the Year Award for Remestemcel-l
12:00am